The Journal of Immunology, Vol 150, Issue 10 4591-4599, Copyright © 1993 by American Association of Immunologists

ARTICLES

Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl- L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E

K Wenzel-Seifert and R Seifert
Institut fur Pharmakologie, Freie Universitat Berlin, Federal Republic of Germany.

The cyclic undecapeptide, cyclosporin (Cs) H, is a potent inhibitor of FMLP-induced superoxide anion (O2-) formation in human neutrophils. We studied the effects of CsH in comparison with those of N-t- butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L- phenylalanine (BocPLPLP), a well known formyl peptide receptor antagonist, and of other Cs on activation of N6,2'-O-dibutyryl adenosine 3:5'-monophosphate-differentiated HL-60 cells and human erythroleukemia cells (HEL cells). CsH inhibited FMLP binding in HL-60 membranes with a Ki (inhibition constant) of 0.10 microM. CsH inhibited activation by FMLP of high affinity GTPase (the enzymatic activity of alpha-subunits of heterotrimeric regulatory guanine nucleotide-binding proteins) in HL-60 membranes with a Ki of 0.79 microM. CsH inhibited the stimulatory effects of FMLP on cytosolic Ca2+ concentration ([Ca2+]i), O2- formation, and beta-glucuronidase release with Ki values of 0.08, 0.24, and 0.45 microM, respectively. BocPLPLP was 14-fold less potent than CsH in inhibiting FMLP binding and 4- to 6-fold less potent than CsH in inhibiting FMLP-induced GTP hydrolysis, rises in [Ca2+]i, O2- formation, and beta-glucuronidase release. CsA reduced FMLP-induced O2- formation by 20%, but CsB, CsC, CsD, and CsE did not. CsA, CsB, CsC, CsD, and CsE did not affect FMLP-induced rises in [Ca2+]i. BocPLPLP inhibited leukotriene B4-induced rises in [Ca2+]i with a Ki of 0.33 microM, whereas CsH showed no inhibitory effect. CsH and BocPLPLP did not inhibit the rises in [Ca2+]i induced by several other stimuli in HL-60 cells and HEL cells. Our results show that 1) CsH is a more potent formyl peptide receptor antagonist than BocPLPLP; 2) unlike BocPLPLP, CsH is selective; and 3) N-methyl-D-valine which is present at position 11 of the amino acid sequence of CsH but not of other Cs is crucial for FMLP antagonism.

This article has been cited by other articles:

				A. Viswanathan, R. G. Painter, N. A. Lanson Jr., and G. Wang Functional Expression of N-Formyl Peptide Receptors in Human Bone Marrow-Derived Mesenchymal Stem Cells Stem Cells, May 1, 2007; 25(5): 1263 - 1269. [Abstract] [Full Text] [PDF]

				P. Yan, M. Nanamori, M. Sun, C. Zhou, N. Cheng, N. Li, W. Zheng, L. Xiao, X. Xie, R. D. Ye, et al. The Immunosuppressant Cyclosporin A Antagonizes Human Formyl Peptide Receptor through Inhibition of Cognate Ligand Binding J. Immunol., November 15, 2006; 177(10): 7050 - 7058. [Abstract] [Full Text] [PDF]

				H. Fu, J. Karlsson, J. Bylund, C. Movitz, A. Karlsson, and C. Dahlgren Ligand recognition and activation of formyl peptide receptors in neutrophils J. Leukoc. Biol., February 1, 2006; 79(2): 247 - 256. [Full Text] [PDF]

				P.-J. Haas, C. J. C. de Haas, W. Kleibeuker, M. J. J. G. Poppelier, K. P. M. van Kessel, J. A. W. Kruijtzer, R. M. J. Liskamp, and J. A. G. van Strijp N-Terminal Residues of the Chemotaxis Inhibitory Protein of Staphylococcus aureus Are Essential for Blocking Formylated Peptide Receptor but Not C5a Receptor J. Immunol., November 1, 2004; 173(9): 5704 - 5711. [Abstract] [Full Text] [PDF]

				Y.-S. Bae, H. Y. Lee, E. J. Jo, J. I. Kim, H.-K. Kang, R. D. Ye, J.-Y. Kwak, and S. H. Ryu Identification of Peptides That Antagonize Formyl Peptide Receptor-Like 1-Mediated Signaling J. Immunol., July 1, 2004; 173(1): 607 - 614. [Abstract] [Full Text] [PDF]

				B. Postma, M. J. Poppelier, J. C. van Galen, E. R. Prossnitz, J. A. G. van Strijp, C. J. C. de Haas, and K. P. M. van Kessel Chemotaxis Inhibitory Protein of Staphylococcus aureus Binds Specifically to the C5a and Formylated Peptide Receptor J. Immunol., June 1, 2004; 172(11): 6994 - 7001. [Abstract] [Full Text] [PDF]

				M. J. Bouchard, R. J. Puro, L. Wang, and R. J. Schneider Activation and Inhibition of Cellular Calcium and Tyrosine Kinase Signaling Pathways Identify Targets of the HBx Protein Involved in Hepatitis B Virus Replication J. Virol., July 15, 2003; 77(14): 7713 - 7719. [Abstract] [Full Text] [PDF]

				R. Seifert and K. Wenzel-Seifert Defective Gi Protein Coupling in Two Formyl Peptide Receptor Mutants Associated with Localized Juvenile Periodontitis J. Biol. Chem., November 2, 2001; 276(45): 42043 - 42049. [Abstract] [Full Text] [PDF]

				S. Spisani, E. Fabbri, M. Muccinelli, A. Cariani, L. Barbin, F. Trotta, and L. Dovigo Inhibition of neutrophil responses by cyclosporin A. An insight into molecular mechanisms Rheumatology, July 1, 2001; 40(7): 794 - 800. [Abstract] [Full Text] [PDF]

				C. Dahlgren, T. Christophe, F. Boulay, P. N. Madianos, M. J. Rabiet, and A. Karlsson The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A4 receptor Blood, March 1, 2000; 95(5): 1810 - 1818. [Abstract] [Full Text] [PDF]

				K. Wenzel-Seifert, J. M. Arthur, H.-Y. Liu, and R. Seifert Quantitative Analysis of Formyl Peptide Receptor Coupling to Gialpha 1, Gialpha 2, and Gialpha 3 J. Biol. Chem., November 19, 1999; 274(47): 33259 - 33266. [Abstract] [Full Text] [PDF]

				J.-L. Gao, E. J. Lee, and P. M. Murphy Impaired Antibacterial Host Defense in Mice Lacking the N-formylpeptide Receptor J. Exp. Med., February 15, 1999; 189(4): 657 - 662. [Abstract] [Full Text] [PDF]

				K. Wenzel-Seifert, C. M. Hurt, and R. Seifert High Constitutive Activity of the Human Formyl Peptide Receptor J. Biol. Chem., September 11, 1998; 273(37): 24181 - 24189. [Abstract] [Full Text] [PDF]

				T. Christophe, A. Karlsson, C. Dugave, M.-J. Rabiet, F. Boulay, and C. Dahlgren The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2 J. Biol. Chem., June 8, 2001; 276(24): 21585 - 21593. [Abstract] [Full Text] [PDF]